In a positive start to April, Frankfurt's DAX index experienced a rise of approximately 0.9% after enduring four straight sessions of losses. This uptick occurred despite prevailing uncertainties as the U.S. president prepares to announce new tariffs this Wednesday. Market participants were also keenly observing global business activity metrics and anticipating the Eurozone's preliminary inflation figures for signs that could influence the European Central Bank's future actions. Leading the pack of high-performing equities were Adidas, Siemens Energy, Commerzbank, Fresenius Medical Care, SAP, and Deutsche Bank, with stock gains ranging between 1.4% and 2.7%. Additionally, Bayer's shares increased by more than 1% in anticipation of an upcoming presentation on significant advancements in pharmaceutical research at the notable Pharmaceuticals Media Day, where divisional head Stefan Oelrich is set to speak.